InsidersTradesSigma
Follow the AMPLIA THERAPEUTICS LIMITED share price and the full directors' dealings record of the company, a listed issuer based in Australia. Shares are listed on AU AU, under the authority of ASX. Market capitalisation: €77m. The latest transaction was filed on 24 June 2026 (Initial Substantial Holding). Among the most active insiders: 2. Details of voting power. The full history is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
AMPLIA THERAPEUTICS LIMITED is a company listed on the XASX, focused on developing treatments for serious diseases. It concentrates on innovative therapies based on regenerative medicine approaches.